man |
TDLo |
intravenous |
2300mg/kg/2D (2300mg/kg) |
BLOOD: OXIDANT RELATED (GPD DEFICIENT) ANEMIA |
Annals of Internal Medicine. Vol. 82, Pg. 810, 1975. |
mouse |
LD50 |
intraperitoneal |
643mg/kg (643mg/kg) |
? |
Progress in Mutation Research. Vol. 1, Pg. 682, 1981. |
mouse |
LD50 |
intravenous |
518mg/kg (518mg/kg) |
? |
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 269, 1970. |
mouse |
LD50 |
oral |
3367mg/kg (3367mg/kg) |
? |
National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, |
rat |
LD50 |
intravenous |
> 4gm/kg (4000mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
rat |
LD50 |
oral |
11900mg/kg (11900mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
rat |
LD50 |
subcutaneous |
> 10gm/kg (10000mg/kg) |
? |
Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
women |
LDLo |
intravenous |
900mg/kg (900mg/kg) |
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" |
Archives of Internal Medicine. Vol. 145, Pg. 950, 1985. |